Trilogy Capital’s Corteva CTVA Stock Holding History

Trilogy Capital’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,456	Closed	-$206K	–	408
2026 Q1	$206K	Buy	+2,456	New	+$185K	0.01%	383

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Trilogy Capital's CTVA Position: Q2 2026 in Review

Trilogy Capital sold out of Corteva (CTVA) in Q2 2026, closing a stake of 2,456 shares — an estimated $206K sold.

Trilogy Capital first reported a position in CTVA in Q1 2026 and held it in 1 quarter. The position peaked at $206K in Q1 2026. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

Trilogy Capital reported no remaining Corteva position as of Q2 2026 after selling out during the quarter.
Trilogy Capital sold 2,456 Corteva shares in Q2 2026, an estimated $206K.
Trilogy Capital first reported a position in Corteva in Q1 2026 and held it in 1 quarter.
Trilogy Capital's Corteva position peaked at $206K in Q1 2026.
1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.